A surprising benefit of the Covid-19 vaccine has been found in a new study.
The study published in JAMA Internal Medicine on Monday concluded that those who received the jab in 2024 and 2025 may have a lower risk of Covid-19-related major adverse cardiovascular events, known as MACE.